Woman is suing Ozempic makers Novo Nordisk over claims they were AWARE it can ... trends now
A woman is taking the makers of Ozempic to court over claims the company behind the drug knew it would cause her stomach problems.
Caren Elosua has filed a suit against the pharmaceutical giant Novo Nordisk claiming the weight loss drugs have been causing stomach problems for users.
In court documents, obtained by TMZ, Elosua says that even with the alleged side effects in mind, she was still given Ozempic to help her type-2 diabetes.
The outlet reported the Elosua started taking a 1ml of the drug in April of 2021, and increased it to 2ml a few years after this.
By the end of last year, she claims she was diagnosed with gastroparesis, the weakening of the stomach muscles, claiming the weight loss drug caused it.
Ozempic has FDA approval as a diabetes drug but it has been prescribed off label for weight loss to millions of Americans
Caren Elosua has filed a suit against the pharmaceutical giant Novo Nordisk, their HQ is seen here, claiming the weight loss drugs have been causing stomach problems for users
Elosua claims she suffered from headaches, vomiting, cramping and severe stomach pain and decided to go see a specialist.
The gastroenterologist, she claims, informed her that her stomach muscles had gotten so weak that she couldn't digest food.
In late January, Elosua claims she had her last shot of Ozempic but added that by this point the alleged damage had been done.
Elosua also claims in her suit that she had to be hospitalized due to the constant pain which tore up her abdominal area.
In her suit, she alleges that Novo Nordisk knew this drug would cause her such problems and they continued to manufacture it.
Elosua is not alone in her claims, with patients across America filing suits against Novo Nordisk saying they experienced extreme side effects with the drug.
Most of the patients, like Elosua, claim they suffered from gastroparesis, which is the medical name for paralysis of the stomach.
The condition, which can be life-threatening, causes a build-up of food in the gut and symptoms include nausea, vomiting and severe pain.
A pharmacist holds a box of Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023
In a review of a dozen lawsuits carried out by DailyMail.com in January of this year, nearly all of the lawsuits accuse of Novo Nordisk of failing to warn them of the risks.
At least ten lawsuits have also been filed against Eli Lilly, the maker of Mounjaro, a diabetes drug which works in a similar way to Ozempic and Wegovy and is also prescribed off-label for weight loss.
Eli Lilly is also accused of failing to include proper warnings about Mounjaro's risks.
In one case, a woman who used Ozempic and Mounjaro claims she was diagnosed with gastroparesis which caused her to vomit so much that some of her teeth feel out.
In another, a woman was diagnosed with a 'life-threatening bowel injury' after using Ozempic and underwent surgery which last nearly nine hours. Doctors said
